-
Notifications
You must be signed in to change notification settings - Fork 0
Expand file tree
/
Copy pathCITATION.cff
More file actions
62 lines (62 loc) · 2.19 KB
/
CITATION.cff
File metadata and controls
62 lines (62 loc) · 2.19 KB
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
cff-version: 1.2.0
message: "If you use this work, please cite it as below."
authors:
- family-names: "Vasquez"
given-names: "Anthony J."
name-suffix: "Sr."
affiliation: "Delaware Valley University"
title: "Context-Dependent Pharmacology of Cannabidiol: A Two-Pathway Model Linking Mitochondrial Status to Divergent Cellular Outcomes"
version: 1.2.0
date-released: 2026-02-13
url: "https://github.com/templetwo/cbd-two-pathway-model"
repository-code: "https://github.com/templetwo/cbd-two-pathway-model"
license: CC-BY-4.0
type: article
keywords:
- cannabidiol
- CBD
- VDAC1
- mitochondria
- context-dependent pharmacology
- neuroprotection
- apoptosis
- glioblastoma
- dose-response
- multi-model convergence
- IRIS Gate Evo
- Monte Carlo simulation
abstract: >-
Cannabidiol (CBD) exhibits paradoxical effects across cell types,
inducing apoptosis in glioma and cancer models while conferring
neuroprotection under excitotoxic stress. We propose that CBD acts
as a mitochondrial stress test, with outcomes determined by
pre-existing cellular metabolic status. A two-pathway framework
explains the paradox: (1) at therapeutic concentrations (1-5 μM),
CBD engages TRPV1, 5-HT1A, PPARγ, and GPR55, producing neuroprotective
effects; (2) at higher concentrations (>10 μM), CBD binds VDAC1 on
the outer mitochondrial membrane, triggering apoptosis in metabolically
vulnerable cells. Literature analysis of 70+ papers yielded 90%
concordance with model predictions. Computational validation via
IRIS Gate Evo (five independent AI models) confirmed convergence
on the two-pathway mechanism with large predicted effect sizes
(Cohen's d 0.81-0.95).
references:
- type: article
authors:
- family-names: "Rimmerman"
given-names: "N."
title: "Direct modulation of VDAC1 by cannabidiol"
journal: "Cell Death & Disease"
year: 2013
volume: 4
pages: "e949"
- type: article
authors:
- family-names: "Devinsky"
given-names: "O."
title: "Trial of cannabidiol for drug-resistant seizures in Dravet syndrome"
journal: "New England Journal of Medicine"
year: 2017
volume: 376
issue: 21
pages: "2011-2020"